Clinical Trials Browser

Biliary Tract Neoplasms × Radiation × 90 days × Clear all

NCT03482102 2026-05-04

Durvalumab (MEDI4736) and Tremelimumab and Radiation Therapy in Hepatocellular Carcinoma and Biliary Tract Cancer

Phase 2 Active not recruiting

Gastrointestinal

Biliary Tract Neoplasms, Carcinoma, Hepatocellular